2020
DOI: 10.3390/toxins12120788
|View full text |Cite
|
Sign up to set email alerts
|

The Links between Microbiome and Uremic Toxins in Acute Kidney Injury: Beyond Gut Feeling—A Systematic Review

Abstract: The last years have brought an abundance of data on the existence of a gut-kidney axis and the importance of microbiome in kidney injury. Data on kidney-gut crosstalk suggest the possibility that microbiota alter renal inflammation; we therefore aimed to answer questions about the role of microbiome and gut-derived toxins in acute kidney injury. PubMed and Cochrane Library were searched from inception to October 10, 2020 for relevant studies with an additional search performed on ClinicalTrials.gov. We identif… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
25
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(28 citation statements)
references
References 60 publications
0
25
0
Order By: Relevance
“…Therefore, decreased levels of indole-3-acetate may be translated in loss of intestinal and immune homeostasis. Other indolic compounds are considered to be uremic toxins and were proposed to be a link between microbiota dysbiosis and renal disease [ 158 ]. Uremic toxins not solely impact renal function, but also neurological function, contributing to certain brain disorders [ 159 ].…”
Section: Asd-associated Differences In Gut Microbial Metabolitesmentioning
confidence: 99%
“…Therefore, decreased levels of indole-3-acetate may be translated in loss of intestinal and immune homeostasis. Other indolic compounds are considered to be uremic toxins and were proposed to be a link between microbiota dysbiosis and renal disease [ 158 ]. Uremic toxins not solely impact renal function, but also neurological function, contributing to certain brain disorders [ 159 ].…”
Section: Asd-associated Differences In Gut Microbial Metabolitesmentioning
confidence: 99%
“…Although some reports have raised gut microbiota and its products as therapeutic targets for CKD, the therapeutic potential still remains to be investigated in AKI patients. A recent systematic review shows that modifying the gut microbiota improves the prognosis of AKI [ 70 ]. Among the metabolites of the gut microbiota, SCFA and D-serine reportedly have renoprotective effects in AKI.…”
Section: Gut Microbiota As a Potential Therapeutic Option For Akimentioning
confidence: 99%
“…Rifaximin was found to correlate with a lower rate of AKI and need for RRT in a retrospective study with patients with cirrhosis. Studies of gut–kidney axis in human AKI are lacking [ 88 ]. A role for gut-derived short-chain fatty acids on renoprotection has been proposed, with immunomodulatory properties and protection during IRI [ 89 ].…”
Section: Medium Molecular Weight Moleculesmentioning
confidence: 99%